Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Impala

K-Number: K232035 · 2024-06-07

Decision Date2024-06-07
Product CodeDPS
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Impala is the device name listed in this FDA 510(k) record. The listed applicant is AliveCor, Inc.. It received FDA 510(k) clearance on 2024-06-07 under 510(k) number K232035. The device is classified under product code DPS. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Impala?

Impala is a medical device that received FDA 510(k) clearance on 2024-06-07. The listed applicant is AliveCor, Inc.. The 510(k) number is K232035.

When did Impala receive FDA 510(k) clearance?

Impala received FDA 510(k) clearance on 2024-06-07, under 510(k) number K232035.

Who is the listed applicant for Impala?

The FDA 510(k) record lists AliveCor, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Impala?

The FDA product code for Impala is DPS.

Other records listing AliveCor, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 13 devices →

Related Devices (Code: DPS)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.